About Us
Overview
Our Vision & Values
Milestones
Leadership
Awards & Recognition
CSR
Our Business
Overview
Formulations
Biologics
APIs
Research
Overview
Formulations
APIs
R&D Locations
Manufacturing
Investors
Financials and Reports
Share, Governance and Investor Services
Offer Documents
Disclosures Under Regulation 46 of SEBI (LODR) Regulations
Other Disclosures
Media
Care
Careers
Newsroom
Contact Us
Media
Share, Governance and Investor Services | Emcure Pharmaceuticals New
Filings | Emcure Pharmaceuticals
Disclosures Under Regulation 46 of SEBI (LODR) Regulations
Other Disclosures
Offer Documents
Media
Media
Press Releases
Emcure Pharmaceuticals Signs Agreement with Gilead for the Manufacture and Global Supply of Lenacapavir
03.10.2024
Download
Emcure Pharmaceuticals Announces Strong Q1FY25 Results with 17% Revenue Growth and 16% EBITDA Growth
13.08.2024
Download
Emcure Pharmaceuticals strengthens its commitment to energy conservation, signs PPA with Sunsure Energy for solar power.
25.07.2024
Download
Quick Explore
About Us
Career
Contact Us
Manufacturing
Newsroom
Our Business
Research